Paul Berggreen
Gastroenterology · Phoenix, AZNPI 1093703605
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Gastrogpo, LLC accounts for 64.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $4,998 and has fallen 86.4% since, to $679 in 2025.
Across 68 payments — averaging $139.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gastrogpo, LLC$6K
- AbbVie$986
- Boston Scientific$547
- Lilly USA, LLC$449
- Pfizer$406
- Medtronic$174
- plus $782 from 13 others
What the payments were for
- Speaking & faculty fees$2142%
- Travel & lodging$4,11443%
- Food & beverage$5,14354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gastrogpo, LLC | 7 | $6,127 |
| AbbVie | 24 | $986 |
| Boston Scientific | 6 | $547 |
| Lilly USA, LLC | 6 | $449 |
| Pfizer | 5 | $406 |
| Medtronic | 3 | $174 |
| Regeneron Healthcare Solutions, Inc. | 2 | $165 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Intercept Pharmaceuticals, Inc. | 1 | $51 |
| Sanofi | 2 | $47 |
| Ironwood Pharmaceuticals, Inc | 2 | $38 |
| UCB, Inc. | 1 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Abbott | 1 | $27 |
| Boehringer Ingelheim | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,471 in reported general payments places this provider in the 70th percentile of 355 gastroenterology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $88,332 |
| Omeprazole | 21 | $350 |
| Pantoprazole Sodium | 20 | $326 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Phoenix
- Moises Nevah RubinPhoenix$183K
- Alan SheinbaumPhoenix$81K
- Divyesh SejpalPhoenix$45K
- Bradford GelzaydPhoenix$26K
- Rawad MounzerPhoenix$22K
- Aws AlameriPhoenix$20K
- Jonathan MellenPhoenix$17K
- Sarabdeep MannPhoenix$16K
- Layth Al-JashaamiPhoenix$13K
- Joel BrillParadise Valley$847K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.